Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
6
NCT02995993
Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2016
Completion: Oct 9, 2017